Autologous and allogeneic blood transfusions in colorectal cancer
(Autologe en allogene bloedtransfusies bij het colorectaal carcinoom)
1995-06-08
Doctoral Thesis
| Related Files |
|---|
View PDF Version
(950608_BUSCH, Olivier Robert Christoffel.pdf, 2.4MB) |
|
View PDF Version
(stellingen busch.pdf, 0.1MB) |
Since blood transfusion became a therapeutical option in patient care, the surgical possibilities have increased tremendously. Since the problems of anticoagulation and blood group typing were largely resolved, blood transfusions were in only a minority of cases directly lethal. However, it was estimated that still up to 20% of the blood transfusions induces a sort of adverse side-effect. Because the most important side-effects are a result of the transmission of infections and the induction of immunological reactions, these are further discussed.
Supervisor
(promotor):
The
author
wishes to thank:
Dutch Cancer Society (KWF),
Dutch Foundation for Preventive Medicine
Keywords
Automatically Extracted Terms
- blood
- transfusion
- patient
- cancer
- blood transfusions
- autologou
- group
- colorectal
- allogeneic
- study
- effect
- donation
- colorectal cancer
- tumor
- recurrence
- colorectal cancer patients
- blood transfusion
- survival
- prognosis
- surgery
